within Pharmacolibrary.Drugs.ATC.R;

model R01AD13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.52,
    Cl             = 0.03333333333333333,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.0029,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Ciclesonide is a corticosteroid used as a nasal spray or inhaler for the treatment of allergic rhinitis and asthma. It is a prodrug that is activated to des-ciclesonide in the lungs. Ciclesonide is approved for use in many countries as an anti-inflammatory agent for respiratory diseases.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intranasal administration of ciclesonide.</p><h4>References</h4><ol><li><p>Nave, R, et al., &amp; Wingertzahn, MA (2009). Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers. <i>Clinical therapeutics</i> 31(12) 2988–2999. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2009.12.002&quot;>10.1016/j.clinthera.2009.12.002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20110036/&quot;>https://pubmed.ncbi.nlm.nih.gov/20110036</a></p></li><li><p>Wolthers, OD (2010). Relevance of pharmacokinetics and bioavailability of intranasal corticosteroids in allergic rhinitis. <i>Recent patents on inflammation &amp; allergy drug discovery</i> 4(2) 118–123. DOI:<a href=&quot;https://doi.org/10.2174/187221310791163035&quot;>10.2174/187221310791163035</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20001898/&quot;>https://pubmed.ncbi.nlm.nih.gov/20001898</a></p></li><li><p>Dhillon, S, &amp; Wagstaff, AJ (2008). Ciclesonide nasal spray: in allergic rhinitis. <i>Drugs</i> 68(6) 875–883. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200868060-00009&quot;>10.2165/00003495-200868060-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18416590/&quot;>https://pubmed.ncbi.nlm.nih.gov/18416590</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R01AD13;
